---
title: "Vivoryon Therapeutics NV to Present at World Congress of Nephrology"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271742260.md"
datetime: "2026-01-07T06:00:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271742260.md)
  - [en](https://longbridge.com/en/news/271742260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271742260.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/271742260.md) | [English](https://longbridge.com/en/news/271742260.md)


# Vivoryon Therapeutics NV to Present at World Congress of Nephrology

Vivoryon Therapeutics N.V., a clinical stage biotechnology company focused on developing small molecule medicines for kidney diseases, will participate in the World Congress of Nephrology (WCN) in Yokohama, Japan, from March 28-31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivoryon Therapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001157972-en) on January 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## 相關資訊與研究

- [Rusoro Mining (CVE:RML) Director Sells 60,000 Shares](https://longbridge.com/zh-HK/news/281694931.md)
- [Should Record 2025 Output and 100% U.S. Reserve Replacement Require Action From Freehold (TSX:FRU) Investors?](https://longbridge.com/zh-HK/news/281696598.md)
- [Is Netflix a Buy After Its Most Recent Price Hike?](https://longbridge.com/zh-HK/news/281711609.md)
- [Wasion Holdings Limited (3393) Gets a Buy from China Renaissance](https://longbridge.com/zh-HK/news/281702521.md)
- [Global Prosperity Sticks to Their Buy Rating for Fufeng Group Limited (FFO1)](https://longbridge.com/zh-HK/news/281702206.md)